Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours.

Baheti G, McGuire TR, Davda JP, Manouilov KK, Wall D, Gwilt PR, Gordon BB.

Xenobiotica. 2013 Mar;43(3):276-82. doi: 10.3109/00498254.2012.713530. Epub 2012 Aug 29.

PMID:
22931186
2.

A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs.

Davda JP, Jain M, Batra SK, Gwilt PR, Robinson DH.

Int Immunopharmacol. 2008 Mar;8(3):401-13. doi: 10.1016/j.intimp.2007.10.023. Epub 2007 Nov 26.

PMID:
18279794
3.

Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.

Wang D, Sima M, Mosley RL, Davda JP, Tietze N, Miller SC, Gwilt PR, Kopeckov√° P, Kopecek J.

Mol Pharm. 2006 Nov-Dec;3(6):717-25.

4.

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK.

Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. Epub 2004 Oct 2.

PMID:
15791435
5.

Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients.

Gwilt PR, Manouilov KK, McNabb J, Swindells SS.

J Clin Pharmacol. 2003 Sep;43(9):1003-7.

PMID:
12971033
6.

The effect of age on the early disposition of doxorubicin.

Li J, Gwilt PR.

Cancer Chemother Pharmacol. 2003 May;51(5):395-402. Epub 2003 Apr 1.

PMID:
12679882
7.

In vitro pharmacokinetics and pharmacodynamics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

Ueda-Kawamitsu H, Lawson TA, Gwilt PR.

Biochem Pharmacol. 2002 Apr 1;63(7):1209-18.

PMID:
11960597
8.

The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis.

Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, Whalen J, Brown RH Jr.

Neurology. 1999 Apr 22;52(7):1492-4.

PMID:
10227642
9.

Pharmacokinetics of 2-oxothiazolidine-4-carboxylate, a cysteine prodrug, and cysteine.

Gwilt PR, Radick LE, Li XY, Whalen JJ, Leaf CD.

J Clin Pharmacol. 1998 Oct;38(10):945-50.

PMID:
9807976
10.

Colorimetric determination of hydroxyurea in human serum using high-performance liquid chromatography.

Manouilov KK, McGuire TR, Gwilt PR.

J Chromatogr B Biomed Sci Appl. 1998 Apr 24;708(1-2):321-4.

PMID:
9653981
11.

Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection.

Manouilov KK, McGuire TR, Gordon BG, Gwilt PR.

J Chromatogr B Biomed Sci Appl. 1998 Apr 10;707(1-2):342-6.

PMID:
9613971
12.

Pharmacokinetics and pharmacodynamics of hydroxyurea.

Gwilt PR, Tracewell WG.

Clin Pharmacokinet. 1998 May;34(5):347-58. Review.

PMID:
9592619
13.

Population pharmacokinetics of glyburide in patients with well-controlled diabetes.

Tracewell WG, Stalker DJ, Maloley PA, Gallagher TF, Gwilt PR.

Pharmacotherapy. 1998 Jan-Feb;18(1):51-6.

PMID:
9469681
14.

Population pharmacokinetics of hydroxyurea in cancer patients.

Tracewell WG, Trump DL, Vaughan WP, Smith DC, Gwilt PR.

Cancer Chemother Pharmacol. 1995;35(5):417-22.

PMID:
7850924
15.

Nonlinear disposition of hydroxyurea.

Tracewell WG, Vaughan WP, Gwilt PR.

J Pharm Sci. 1994 Jul;83(7):1060-1. No abstract available.

PMID:
7965665
16.

The effect of garlic extract on human metabolism of acetaminophen.

Gwilt PR, Lear CL, Tempero MA, Birt DD, Grandjean AC, Ruddon RW, Nagel DL.

Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):155-60.

17.

Clofibrate enhances the DNA damaging action and cytotoxicity of nitrosoureas.

Lawson T, Gwilt PR.

Cancer Lett. 1993 Jun 15;70(1-2):119-22.

PMID:
8330293
18.

A phase I trial of high-dose continuous-infusion hydroxyurea.

Smith DC, Vaughan WP, Gwilt PR, Trump DL.

Cancer Chemother Pharmacol. 1993;33(2):139-43.

PMID:
8261572
19.

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Gwilt PR, Nahhas RR, Tracewell WG.

Clin Pharmacokinet. 1991 Jun;20(6):477-90. Review.

PMID:
2044331
20.

Pharmacokinetics of disopyramide in the dog. Importance of mono-N-dealkylated metabolite kinetics in assessing pharmacokinetic modeling of the parent drug.

Cook CS, Gwilt PR, Kowalski K, Gupta S, Oppermann J, Karim A.

Drug Metab Dispos. 1990 Jan-Feb;18(1):42-9.

PMID:
1970776
21.

Time to steady state following a change in dosing rate.

D'Angio RG, Gwilt PR.

DICP. 1989 Jun;23(6):468-72.

PMID:
2741481
22.

Removal of sulfonamides by hemofiltration.

Yu SS, Waters DH, Shen SH, Lempert KD, Gwilt PR.

Biopharm Drug Dispos. 1989 Mar-Apr;10(2):173-85.

PMID:
2706317
23.

The influence of diffusional barriers on presystemic gut elimination.

Gwilt PR, Comer S, Chaturvedi PR, Waters DH.

Drug Metab Dispos. 1988 Jul-Aug;16(4):521-6.

PMID:
2903017
25.

Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.

Chaturvedi PR, O'Donnell JP, Nicholas JM, Shoenthal DR, Waters DH, Gwilt PR.

Int J Clin Pharmacol Ther Toxicol. 1987 Mar;25(3):123-8.

PMID:
3557737
26.

The effect of activated charcoal on mouse sleep times induced by intravenously administered hypnotics.

Adler LJ, Waters DH, Gwilt PR.

Biopharm Drug Dispos. 1986 Sep-Oct;7(5):421-9.

PMID:
3779033
27.

High-performance liquid chromatographic determination of terfenadine in commercial tablets.

Gupta SK, Gwilt PR, Lim JK, Waters DH.

J Chromatogr. 1986 Jun 27;361:403-6. No abstract available.

PMID:
3090082
28.

Absorption and disposition of aluminum in the rat.

Gupta SK, Waters DH, Gwilt PR.

J Pharm Sci. 1986 Jun;75(6):586-9.

PMID:
3735104
29.
30.

Pharmacokinetics of methyprylon following a single oral dose.

Gwilt PR, Pankaskie MC, Thornburg JE, Zustiak R, Shoenthal DR.

J Pharm Sci. 1985 Sep;74(9):1001-3.

PMID:
2866242
31.

Computerized drug therapy: application of the hand-held microcomputer to dosage regimen design.

Brouwer KR, Cook J, Steinke M, Gwilt PR.

Int J Biomed Comput. 1985 Jul;17(1):49-55.

32.

Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.

Smith RB, Gwilt PR, Wright CE 3rd.

Clin Pharm. 1983 Mar-Apr;2(2):139-43.

PMID:
6883942
33.

The effect of oral castor oil on the disposition of methyprylon in intoxicated dogs.

Gwilt PR, Pankaskie MC, Mitala JJ.

Can Anaesth Soc J. 1982 Jul;29(4):381-3.

PMID:
6125250
34.

General equation for assessing drug removal by extracorporeal devices.

Gwilt PR.

J Pharm Sci. 1981 Mar;70(3):345-6. No abstract available.

PMID:
7264909
35.
36.

Influence of "thickening" agents on the antidotal efficacy of activated charcoal.

Gwilt PR, Perrier D.

Clin Toxicol. 1976;9(1):89-92.

PMID:
1277772
37.

Particulate matter in reconstituted amphotericin B and assay of filtered solutions of amphotericin B.

Piecoro JJ, Goodman NL, Wheeler WE, Gwilt PR, Rapp RP.

Am J Hosp Pharm. 1975 Apr;32(4):381-4.

PMID:
1093398
38.

Activated charcoal for acute acetaminophen intoxication.

Levy G, Gwilt PR.

JAMA. 1972 Jan 31;219(5):621. No abstract available.

PMID:
5066812

Supplemental Content

Loading ...
Support Center